Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain

• मुख्य लेखकों: R. Ariza (लेखक), A. van Walsem (लेखक), C. Canal (लेखक), C. Roldán (लेखक), L. Betegón (लेखक), I. Oyagüez (लेखक), K. Janssen (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2014-07-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Objective: To compare the cost of treating rheumatoid arthritis patients that have failed an initial treatment with methotrexate, with subcutaneous aba - tacept versus other first-line biologic disease-modifying antirheumatic drugs. Method: Subcutaneous abatacept was considered comparable to intrave...